Fundamental Analysis of Amedisys Inc - Growth / Value Index
AMED - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0.0111
Book Value in last 3 years is trending up
Tsr Value Index - Poor Score of 31.25
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 36.24 | 1162.51 | 4289.12 % | |
| Price to Book | 2.79 | 2.75 | -3.17 % | 2.73 |
| Price to Sales | 1.38 | 1.38 | -2.21 % | |
| Enterprise Value to EBITDA Multiple | 188.58 | 36.76 | 88.91 % |
AMED - Profitability Highlights
Profitability Analysis
Company Earning excess return
Tsr Profitability Index - Very Poor Score of 18.12
Very Low Dividend Yield of 0.630 %
Low Earning Yield of 2.72 %
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 8.10 | 0.248 | -97.80 % | 3.66 |
| Return On Asset | 4.23 | 0.129 | -97.86 % | 1.91 |
| Net Profit Margin | 3.80 | 0.119 | -97.77 % | 6.98 |
| Operating Profit Margin | 1.69 | 8.70 | 6.98 % | 5.53 |
| EBITDA Margin | 0.792 | 4.10 | -50.32 % | 4.09 |
Highlights
| Market Cap | 3085.68 M |
| Enterprise Value | 3364.28 M |
| Price/Book TTM | 2.79 |
| Outstanding Share | 32676.90 K |
| Float/ Outstanding Share | 97.96% |
| Dividend Yield | 0.630 % |
Share Holding
Guru Numbers
| Price/Graham No | 2.10 |
| Peter Lynch Ratio | -2.70 |
| Piotroski F Score | 6.00 |
| Altman Z Score | 3.68 |
| Sloan Ratio | -0.056 |
| Peter Lynch Fair Value | 0 |
AMED - Growth Highlights
Growth Analysis
Short term positive trend in total sale and net profit
Annual sales of the company is increased for three years in a row
Quarterly sales in last 5 years is trending up
Steady increase in Total Assets for last 3 Years
Tsr Growth Index - Poor Score of 21.38
Operating Cash Flow decreasing for last 3 year
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 2251.41 M | 0.201 % | 0.110 % |
| Gross Profit | 1728.27 M | 55.63 % | 3.09 % |
| EBITDA | 17840.00 K | 50.22 % | 6.88 % |
| Net Profit | 85533.00 K | 97.77 % | 1.23 % |
| EPS | 2.61 | 97.72 % | NA |
AMED - Stability Highlights
Stability Analysis
Altman Z Score of 3.71 suggests good Stability
Decreasing debt with Increasing revenue
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.398 | -10.66 % | 0.386 |
| Cash Ratio | 0.308 | 170.03 % | |
| Quick Ratio | 0 | 0 % | 1.09 |
| Shareholders Equity | 51.77 | -2.71 % | |
| Debt to EBITDA | 4.65 | 82.01 % |
Historical Valuation Ratios of Amedisys Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Amedisys Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Amedisys Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Amedisys Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)